Femasys Future Growth
Future criteria checks 2/6
Femasys is forecast to grow earnings and revenue by 20.6% and 62.2% per annum respectively while EPS is expected to grow by 40.4% per annum.
Key information
20.6%
Earnings growth rate
40.4%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 62.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Femasys (NASDAQ:FEMY) Has Debt But No Earnings; Should You Worry?
Oct 31
Shareholders May Be More Conservative With Femasys Inc.'s (NASDAQ:FEMY) CEO Compensation For Now
Jul 05Health Check: How Prudently Does Femasys (NASDAQ:FEMY) Use Debt?
Apr 03Here's Why We're Watching Femasys' (NASDAQ:FEMY) Cash Burn Situation
Sep 27Femasys commercially launches Femcerv for cervical cancer screening
Sep 29Femasys GAAP EPS of -$0.22 beats by $0.01, revenue of $0.3M misses by $0.01M
Aug 10We Think Femasys (NASDAQ:FEMY) Needs To Drive Business Growth Carefully
May 22Femasys: Revolutionizing Female Reproduction
Jul 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 18 | -22 | -15 | N/A | 2 |
| 12/31/2025 | 10 | -19 | -18 | N/A | 4 |
| 12/31/2024 | 3 | -18 | -10 | N/A | 4 |
| 9/30/2024 | 1 | -18 | -18 | -17 | N/A |
| 6/30/2024 | 1 | -17 | -15 | -15 | N/A |
| 3/31/2024 | 1 | -15 | -13 | -13 | N/A |
| 12/31/2023 | 1 | -14 | -11 | -11 | N/A |
| 9/30/2023 | 1 | -13 | -11 | -11 | N/A |
| 6/30/2023 | 1 | -12 | -11 | -11 | N/A |
| 3/31/2023 | 1 | -11 | -11 | -11 | N/A |
| 12/31/2022 | 1 | -11 | -11 | -11 | N/A |
| 9/30/2022 | 1 | -11 | -11 | -10 | N/A |
| 6/30/2022 | 1 | -10 | -10 | -9 | N/A |
| 3/31/2022 | 1 | -9 | -10 | -10 | N/A |
| 12/31/2021 | 1 | -8 | -8 | -8 | N/A |
| 9/30/2021 | 1 | -7 | -7 | -7 | N/A |
| 6/30/2021 | 1 | -6 | -6 | -6 | N/A |
| 3/31/2021 | 1 | -7 | -4 | -4 | N/A |
| 12/31/2020 | 1 | -7 | -5 | -5 | N/A |
| 12/31/2019 | 1 | -11 | -12 | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FEMY is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: FEMY is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: FEMY is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: FEMY's revenue (62.2% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: FEMY's revenue (62.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if FEMY's Return on Equity is forecast to be high in 3 years time